Tag Archives: S.296

Congress Probes Drug Shortages

Drug shortages in the US are a growing crisis, members of Congress were told last Friday, September 23.  And there is no single reason why this is happening and no easy solutions to the problem. Problems lie mostly in older generic versions of sterile injectable drugs, which are low-priced and complicated to manufacture made by a only a few companies manufactured in aging plants where quality is hard to maintain.

Growing Drug Shortages Cost Money, Put Patients at Risk

Shortages of prescription drugs cost the United States more than $200 million. In addition, shortages force doctors to delay or cancel treatment.  Patient safety is compromised when doctors have to use different or unfamiliar drugs when they can’t get the right ones. In the six months from July to December of 2010, 240 drugs were either in short supply or completely unavailable.  More than 400 generics were back-ordered for more than five days. Most of the medicines with shortages are necessary for emergency care, sedation, or chemotherapy — including leucovorin which is a backbone of most colorectal cancer treatment regimens.

Top